1. Evaluation of platelet function under high shear condition in the small-sized collagen bead column
- Author
-
Kaneo Satoh, Yukio Ozaki, Makoto Kaneko, Morio Arai, Toshiro Takafuta, Yutaka Yatomi, and Olga Cuyun-Lira
- Subjects
Blood Platelets ,Platelet Aggregation ,Platelet Function Tests ,Platelet Glycoprotein GPIIb-IIIa Complex ,Platelet membrane glycoprotein ,Antibodies ,Pathology and Forensic Medicine ,chemistry.chemical_compound ,Thromboxane A2 ,Von Willebrand factor ,hemic and lymphatic diseases ,von Willebrand Factor ,Von Willebrand disease ,medicine ,Humans ,Platelet ,Platelet activation ,Ristocetin ,Blood Coagulation ,Platelet-poor plasma ,Chromatography ,biology ,Chemistry ,General Medicine ,Platelet Activation ,medicine.disease ,Platelet Glycoprotein GPIb-IX Complex ,Biochemistry ,Biophysics ,biology.protein ,Collagen ,Rheology ,Shear Strength - Abstract
We previously reported that platelet retention rates as measured with collagen-coated bead columns (the conventional column) reflect the processes of platelet adhesion and aggregation under low shear stress, and that this system could serve as an easy-to-use platelet aggregometry. With this column, platelet glycoprotein (GP) VI and GPIIb/IIIa, but not the GPIb-von Willebrand factor (VWF) interaction, play major roles in platelet activation. To develop a system that can better reflect the GPIb-VWF interaction under high shear stress, we designed a column containing small-sized beads (125-212 microm) coated with porcine collagen type I. As expected, the GPIb-VWF interaction played a crucial role in platelet retention rates at higher flow rates. Adenosine 5'-diphosphate, but not thromboxane A2, appears to support platelet activation in this system. The platelet retention rates among healthy individuals with the new columns are in the range wider than the conventional columns, and this diversity could be attributed to the broad range of the VWF antigen and/or its activity. It is suggested that this new column can serve as an easy-to-use method for evaluating the VWF antigen levels and its activity and for monitoring patients with thrombotic or bleeding disorders related to the VWF-GPIb interaction.
- Published
- 2005